Redmile Group, LLC

13F Filings History

Latest 13F report
Q3 2024 - Nov 14, 2024
Value $
$1.7B
Signature - Title
Jennifer Ciresi - General Counsel and Chief Compliance Officer
Location
San Francisco, CA
Summary
This page shows a list of all the recent 13F filings made by Redmile Group, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Redmile Group, LLC reported 63 stock holdings with total value $1.7B as of Q3 2024. Top holdings included KRYS, NRIX, FOLD, IMNM, and KYMR.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2024 63 $1.7B +$43.8M -$155M -$111M KRYS, NRIX, FOLD, IMNM, KYMR 13F-HR 11/14/2024, 04:15 PM
Q2 2024 63 $1.65B +$47M -$529M -$482M KRYS, FOLD, NRIX, STOK, IMNM 13F-HR 8/14/2024, 04:16 PM
Q1 2024 77 $2.72B +$468M -$882M -$414M KRYS, FOLD, IMNM, SRRK, FATE 13F-HR 5/15/2024, 04:50 PM
Q4 2023 70 $2.8B +$465M -$319M +$145M IMGN, KRYS, FOLD, SRRK, RYZB 13F-HR 2/14/2024, 04:16 PM
Q3 2023 68 $2.1B +$137M -$372M -$235M IMGN, KRYS, FOLD, AKRO, AUGX 13F-HR 11/14/2023, 04:15 PM
Q2 2023 72 $2.61B +$487M -$443M +$43.5M IMGN, KRYS, FOLD, REPL, AKRO 13F-HR 8/14/2023, 04:15 PM
Q1 2023 76 $2.3B +$383M -$273M +$111M FOLD, KRYS, ISEE, DCPH, AKRO 13F-HR 5/15/2023, 04:15 PM
Q4 2022 69 $2.44B +$290M -$327M -$36.5M FOLD, KRYS, AKRO, REPL, FATE 13F-HR 2/14/2023, 04:18 PM
Q3 2022 70 $2.58B +$313M -$485M -$171M FATE, FOLD, KRYS, ARGX, PLRX 13F-HR 11/14/2022, 04:03 PM
Q2 2022 71 $2.62B +$275M -$149M +$125M FATE, FOLD, SGEN, ARGX, KRYS 13F-HR 8/15/2022, 05:22 PM
Q1 2022 70 $3.19B +$179M -$180M -$1.25M FATE, FOLD, ARGX, LIVN, KRYS 13F-HR 5/16/2022, 04:13 PM
Q4 2021 71 $4.4B +$449M -$735M -$286M FATE, FOLD, SNCE, ARGX, LIVN 13F-HR 2/14/2022, 05:07 PM
Q3 2021 75 $5.73B +$516M -$714M -$198M FATE, ALLK, IGMS, ARGX, ADCT 13F-HR 11/15/2021, 04:16 PM
Q2 2021 86 $6.76B +$476M -$812M -$336M FATE, IGMS, BEAM, ARGX, FOLD 13F-HR 8/16/2021, 05:00 PM
Q1 2021 86 $7.1B +$1.13B -$1.4B -$261M FATE, ALLK, IGMS, ARGX, FOLD 13F-HR 5/17/2021, 04:05 PM
Q4 2020 87 $8.25B +$1.61B -$739M +$872M FATE, FOLD, ALLK, BEAM, IGMS 13F-HR 2/16/2021, 04:06 PM
Q3 2020 81 $5.45B +$1.15B -$1.07B +$83.4M FATE, FOLD, IMMU, ARGX, IGMS 13F-HR 11/16/2020, 04:09 PM
Q2 2020 80 $5.42B +$1.48B -$724M +$755M FATE, FOLD, DCPH, ADCT, ARGX 13F-HR 8/14/2020, 04:16 PM
Q1 2020 69 $3.57B +$674M -$674M +$230K FATE, FOLD, DCPH, BIIB, IGMS 13F-HR 5/15/2020, 04:04 PM
Q4 2019 64 $4.18B +$1.11B -$854M +$260M DCPH, ALLK, FOLD, FATE, EPZM 13F-HR 2/14/2020, 04:10 PM
Q3 2019 74 $2.99B +$709M -$838M -$129M ALLK, FOLD, FATE, DCPH, ALDR 13F-HR 11/14/2019, 04:11 PM
Q2 2019 80 $3.53B +$596M -$639M -$43.3M ARRY, FOLD, FATE, ARGX, QURE 13F-HR 8/14/2019, 04:04 PM
Q1 2019 82 $3.42B +$662M -$300M +$362M ARRY, FOLD, FATE, ATRA, ARGX Restatement 5/17/2019, 08:56 PM
Q4 2018 78 $2.49B +$373M -$590M -$217M ARRY, ATRA, FATE, XNCR, WVE Restatement 5/16/2019, 03:34 PM
Q3 2018 83 $3.25B +$699M -$490M +$209M ARRY, ATRA, FATE, RGNX, XNCR Restatement 5/16/2019, 03:34 PM
Q2 2018 81 $2.94B +$705M -$593M +$112M ARRY, FOLD, ATRA, IMGN, XNCR 13F-HR 8/14/2018, 04:32 PM
Q1 2018 64 $2.59B +$592M -$522M +$69.6M ARRY, ATRA, FOLD, IMGN, XNCR 13F-HR 5/15/2018, 04:30 PM
Q4 2017 1 $6.6M $0 $0 LIFE New Holdings 3/8/2018, 04:01 PM
Q4 2017 70 $2.3B +$678M -$391M +$288M ARRY, FOLD, PBYI, CLVSQ, WVE 13F-HR 2/14/2018, 05:03 PM
Q3 2017 65 $2.03B +$628M -$467M +$161M ARRY, FOLD, PBYI, SGEN, CLVSQ 13F-HR 11/14/2017, 04:23 PM
Q2 2017 62 $1.62B +$374M -$424M -$50.1M ARRY, FOLD, PEN, PBYI, CLVSQ 13F-HR 8/14/2017, 05:39 PM
Q1 2017 60 $1.54B +$489M -$303M +$186M ARRY, PEN, FOLD, PBYI, CLVSQ 13F-HR 5/15/2017, 04:41 PM
Q4 2016 50 $1.16B +$246M -$231M +$15.5M ARRY, SGEN, CLVSQ, PEN, FOLD 13F-HR 2/14/2017, 04:40 PM
Q3 2016 51 $1.26B +$383M -$415M -$31.7M ARRY, SGEN, FOLD, CLVSQ, GWPH 13F-HR 11/14/2016, 06:26 PM
Q2 2016 54 $1.05B +$260M -$255M +$5.19M ARRY, FOLD, MDVN, SGEN, ATRA 13F-HR 8/15/2016, 06:47 PM
Q1 2016 46 $966M +$246M -$342M -$95.5M FOLD, MDVN, CLVSQ, PEN, ARRY 13F-HR 5/16/2016, 05:22 PM
Q4 2015 56 $1.3B +$365M -$380M -$15.3M FOLD, MDVN, PEN, ARRY, ITCI 13F-HR 2/16/2016, 04:53 PM
Q3 2015 58 $1.32B +$735M -$521M +$214M FOLD, CLVSQ, ARRY, MDVN, INCY Restatement 11/17/2015, 03:23 PM
Q2 2015 55 $1.22B +$394M -$366M +$27.5M ARRY, FOLD, VRX, CLVSQ, TEVA 13F-HR 8/14/2015, 04:27 PM
Q1 2015 54 $1.11B +$435M -$346M +$88.3M ARRY, CLVSQ, FOLD, VRX, TEVA 13F-HR 5/15/2015, 07:11 PM
Q4 2014 54 $918M +$210M -$257M -$47.3M FOLD, ARRY, VRX, CMRX, RAD 13F-HR 2/17/2015, 07:28 PM
Q3 2014 52 $812M +$314M -$345M -$30.9M VRX, B108PS, CLVSQ, CELG, FOLD 13F-HR 11/14/2014, 04:29 PM
Q2 2014 47 $822M +$334M -$328M +$5.83M B108PS, MDT, ARRY, UHS, HCA 13F-HR 8/14/2014, 06:52 PM
Q1 2014 55 $838M +$363M -$443M -$80.4M B108PS, HCA, A, VRX, CLVSQ Restatement 8/19/2014, 02:09 PM
Q4 2013 55 $796M $0 $0 GILD, CLVSQ, ZBH, CELG, AZN 13F-HR 2/14/2014, 05:16 PM